RxDoctor Payments Data

Trent Douglas

Plastic and Reconstructive Surgery · Greenbrae, CANPI 1023176302

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 29.9% of the total. Reporting peaked in 2019 at $4,068 and has fallen 76.3% since, to $963 in 2025.

$12,055in general payments, 2019–2025

Across 138 payments — averaging $87.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Pharmaceuticals Incorporated$4K
  • Heron Therapeutics, Inc.$3K
  • AbbVie$2K
  • Motiva USA, LLC$727
  • Davol Inc.$615
  • Musculoskeletal Transplant Foundation Inc.$593
  • plus $1K from 11 others

What the payments were for

  • Consulting fees$6,60155%
  • Travel & lodging$8227%
  • Food & beverage$4,21935%
  • Gifts$871%
  • Other$3263%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,055 in reported general payments places this provider in the 85th percentile of 349 plastic and reconstructive surgery providers in California.

See all plastic and reconstructive surgery providers in California

Other plastic and reconstructive surgery in Greenbrae

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →